FAST: Feasibility of Aerodigestive Stimulation Therapy Trial

Sponsor
Sudarshan Jadcherla (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06118697
Collaborator
(none)
40
1
48

Study Details

Study Description

Brief Summary

The goal of this study is to demonstrate safety, feasibility, and efficacy of a novel pharyngo-esophageal stimulation technique in restoring aerodigestive and swallowing functions in select infants at-risk for chronic gavage tube feeding or gastrostomy. The main aims are:

  • To provide consistent activation of deglutition (the process of swallowing), swallowing-airway interactions, and peristalsis in order to decrease the risk of home tube feeding.

  • To examine whether physical and manometric evidence-guided interventions and biofeedback will improve compliance, minimize parental stress, and increase satisfaction and perceived self-confidence with infant feeding.

Participants will have weekly pharyngo-esophageal stimulation guided by High Resolution Impedance Manometry (HRIM) for 4 weeks or until discharge, oral nutritive stimulation of at least 5 mL of prescribed milk with each feed, and weekly parental education and feedback regarding feeding progress.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Esophageal stimulation with high resolution esophageal manometry and nutritive oral feeding therapy
N/A

Detailed Description

Stimulation will be provided to the esophagus using esophageal manometry starting at enrollment and then weekly for 4 weeks or until discharge, whichever occurs first. During the 4 weeks of study enrollment, subjects will also be provided nutritive oral feeding therapy with each care with a minimum of 5 mL of their prescribed feed. Feeding evaluations by a study team member will occur once a day during the length of the 4-week trial. The study team will do weekly rounds at the bedside to evaluate feeding progress and study interventions. A feeding plan will be posted at the bedside for clear communication with the care team and family of the subjects.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Mechanistic study designMechanistic study design
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Safety and Feasibility of Aerodigestive Stimulation Therapy in Infants With Complex Feeding Difficulties
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2025
Anticipated Study Completion Date :
Nov 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Infants with Complex Feeding Difficulties

Weekly manometric esophageal stimulation as well as consistent nutritive oral feeding therapy

Procedure: Esophageal stimulation with high resolution esophageal manometry and nutritive oral feeding therapy
Subjects will be given weekly pharyngo-esophageal stimulation guided by high resolution impedance manometry for 4 weeks. During this time of study intervention, every feed will start with nutritive oral stimulation with at least 5 mL of the infant's prescribed diet.

Outcome Measures

Primary Outcome Measures

  1. Oral feeding volumes prior to and at the completion of the study [Collected at 4 weeks or prior to discharge]

    Oral feeding volume will be compared prior to the initial manometry study and after the completion of the final manometry study after 4 weeks or prior to discharge, whichever is earliest

  2. Parent surveys [4 weeks or prior to discharge]

    Parental questionnaires will be compared from prior to initial esophageal manometry study and after completion of final esophageal manometry study.

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Day to 8 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • NICU infant ≥37 weeks postmenstrual age not taking full oral feeds

  • Consult to Neonatal & Infant Feeding Disorder Program for oral feeding difficulty with diagnostic manometry ordered

  • Presence of peristaltic and sphincteric reflexes at initial manometry

Exclusion Criteria:
  • Potentially lethal chromosomal anomalies

  • Craniofacial malformations

  • Foregut malformations

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Sudarshan Jadcherla

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sudarshan Jadcherla, Principal Investigator, Innovative Feeding Disorders Research Program, Nationwide Children's Hospital
ClinicalTrials.gov Identifier:
NCT06118697
Other Study ID Numbers:
  • STUDY00000804
First Posted:
Nov 7, 2023
Last Update Posted:
Nov 7, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sudarshan Jadcherla, Principal Investigator, Innovative Feeding Disorders Research Program, Nationwide Children's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 7, 2023